Our working hypothesis is that an elevated BOB1 expression is involved in the pathogenesis of autoimmune diseases [1] and germinal center (GC)-derived lymphomas [2] through the OCT1(2)-mediated engagement of auxiliary genomic targets. This evidence concerns the gene POU2F1 and autoimmune disease.